Low prevalence of vancomycin resistant enterococci colonization in intensive care patients in a Brazilian teaching hospital

Brazilian Journal of Infectious Diseases

Volumn 10, Issue 4, 2006, Pages 239-241

  Tresoldi, Antonia Teresinha ^a,b   Cardoso, Luis Gustavo O ^a   Castilho, Giane V ^a   Dantas, Sônia R P E ^a   von Nowakonski, Angela ^a   Pereira, Ricardo M ^a   Trabasso, Plínio ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

Colonization; Vancomycin resistant enterococci; VRE

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; CEFAZOLIN; CEFEPIME; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; BRAZIL; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; PREVALENCE; TEACHING HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BRAZIL; CHILD, PRESCHOOL; CROSS INFECTION; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; MIDDLE AGED; PREVALENCE; RISK FACTORS; VANCOMYCIN RESISTANCE;

EID: 33947359751     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702006000400004     Document Type: Article

References (28)

1. Uttley A.H., Collins C.H., Naidoo J., et al. Vancomycin-resistant enterococci. Lancet 1988;1:57-8.
2. Leclercq R., Derlot E., Duval J., et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61.
3. Boisivon A., Thibault M., Leclerq R. Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. Clin Microbiol Infect 1997; 3:175-9.
4. Van den Bogard A.E., Mertens P., London N.H., et al. High prevalence of colonization with vancomycin and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: is the addition of antibiotics to animal feed to blame? J Antimicrob Chemother 1997;40:454-6.
5. Seong C.N., Shim E.S., Kim S.M., et al. Prevalence and characterization of vancomycin-resistant enterococci in chickens intestines and humans of Korea. Arch Pharm Res 2004;27:246-53.
6. Simonsen G.S., Andersen B.M., Digranes A., et al. Low Faecal Carrier Rate of Vancomycin Resistant Enterococci in Norwegian Hospital Patients. Scand J Infect Dis 1998;30:465-8.
7. Dalla Costa L.M., Souza D.C., Martins L.T., et al. Vancomycin-resistant Enterococcus faecium: First case in Brazil. Braz J Infect Dis 1998;2:160-3.
8. Maschieto A., Martinez R., Palazzo I.C.V., et al. Antimicrobial resistance of Enterococcus sp. Isolated from the Intestinal Tract of Patients from a University Hospital in Brazil. Mem Inst Oswaldo Cruz 2004;99:763-67.
9. Furtado G.H.C., Martins S.T., Coutinho A.M., et al. Prevalence and Factors Associated with Rectal Vancomycin-resistant enterococci Colonization in Two Intensive Care Units in São Paulo, Brazil. Braz J Infect Dis 2005;9:64-69.
10. Edmond M.B., Ober J.F., Dawson J.D., et al. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996; 23:1234-9.
11. Furtado G.H.C., Martins S.T., Coutinho A.P., et al. Incidência de Enterococcus resistente à vancomicina em hospital universitário no Brasil. Rev Saúde Pública 2005; 39:41-6.
12. Broadhead J.M., Parra D.S., Skelton P.A. Emerging multiresistant organisms in the ICU: epidemiology, risk factors, surveillance and prevention. Crit Care Nurs Q 2001;24:20-9.
13. Husni R., Hachem R., Hanna H., et al. Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol 2002;23:102-3.
14. Suntharam N., Lankford M.G., Trick W.E., et al. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis 2002;43:183-8.
15. Carmeli Y., Eliopoulos G.M., Samore M.H. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002;8:802-7.
16. Zaas A.K., Song X., Tucker P., et al. Risk Factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 2002;15:1139-46.
17. Ho P.L. Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission. Crit Care Med 2003;31:1175-82.
18. Bonten M.J.M., Hayden M.K., Nathan C., et al. The epidemiology of patient colonization and environmental contamination with vancomycin-resistant Enterococcus: the challenge of infection control. Lancet 1996;348:1615-9.
19. Boyce J.M. Vancomycin-resistant enterococcus. Detection, epidemiology and control measures. Infect Dis Clin North Am 1997; 11:367-84.
20. Morris J.G, Shay D.K., Hebden J.N., et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250-9.
21. Montecalvo M.A., De Lencastre H., Carraher M., et al. Natural history of colonization with vancomycin-resistant Enterococcus faecalis. Infect Control Hosp Epidemiol 1995;16:680-5.
22. Christidou A., Nikolaids P., Skoutelis A., et al. Vancomycin-resistant enterococci in Greece: a multicentre prevalence study on intestinal colonization. Cli Microb Infection 2005;11 (suppl 2):223.
23. Barbosa D., Lima L., Silbert S., et al. Evaluation of the prevalence and isk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis. Am J Kidney Dis 2004;44:337-43.
24. Ratanasuwan W., Iwen P.C., Hinrichs S.H., et al. Bacteremia due to motile Enterococcus species: clinical features and outcomes. Clin Infect Dis 1999;28:1175-7.
25. Kurup A., Tee W.S.N., Loo I.H., et al. Infection of central nervous system by motile Enterococcus: first case report. J Clin Microbiol 2001;39:820-2.
26. Reid K.C, Cockerill I.F., Patel R. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin Infect Dis 2001;32:1540-6.
27. Yoko T., Keisuke S., Tohru A. Meningitis caused by Enterococcus gallinarum in patients with ventriculoperitoneal shunts. J Infect Chemoter 2003;9:348-50.
28. Choi S.H., Lee S.O., Kim T.H., et al. Clinical Features and Outcomes of Bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: Analysis of 56 cases. Clin Infect Dis 2004; 38:53-61.